← Leaderboards
Christina A Brezing
New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
$1,421,257
Attributed
$1,421,257
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $435.5K · FY2018–23$500K$375K$250K$125K$0
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,421,257 · 2
By mechanism
K23$981,532 · 1
R21$439,725 · 1
Top collaborators
No co-investigators on record.
Most similar at New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc
Same institution · by research overlap
- Mark Sascha Ansorge$7,963,858
- Claude Ann Mellins$17,536,371
- Katherine S Elkington$13,862,482
- Theodorus G.m. Sandfort$12,695,706
- Christine Tagliaferri Rael$1,527,976
Others in their field
Other Emerging Leaders on “Morbidity - Disease Rate”
- Stephen F Smagula · University Of Pittsburgh At Pittsburgh$5,369,879
- Karen Yazzie · Fort Belknap Indian Community$2,692,724
- Henning Tiemeier · University Of Chicago$2,503,974
- Molly Adrian · Seattle Children'S Hospital$2,302,897
- Shabbar I Ranapurwala · Univ Of North Carolina Chapel Hill$2,061,226
- Elizabeth Van Nostrand · University Of Pittsburgh At Pittsburgh$1,889,694
Research focus
Morbidity - Disease RateOutpatientsGrantSubstance Abuse TreatmentTechnologyPharmaceutical PreparationsEcological Momentary AssessmentFuturePatient Self-ReportRandomizedTrainingVisitClinical TrialsPublic HealthAddictionDropoutEvidence Based PracticeFda ApprovedRandomized Controlled TrialsAdultAreaAdmission ActivityAmbulatory CareAcute
Grant awards (7)
A Randomized, Controlled Trial of Sublingual Buprenorphine through Telemedicine vs In-Person Care as Usual in the Treatment of Opioid Use Disorder$199,875
R21 · FY2023 · DA · contact PI
A Randomized, Controlled Trial of Sublingual Buprenorphine through Telemedicine vs In-Person Care as Usual in the Treatment of Opioid Use Disorder$239,850
R21 · FY2022 · DA · contact PI
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Disorder$195,651
K23 · FY2022 · DA · contact PI
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Disorder$195,977
K23 · FY2021 · DA · contact PI
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Disorder$196,316
K23 · FY2020 · DA · contact PI
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Disorder$196,667
K23 · FY2019 · DA · contact PI
A Randomized Controlled Trial of Lorcaserin for the Treatment of Cannabis Use Disorder$196,921
K23 · FY2018 · DA · contact PI